Aivlosin

1 x 5 kg

Oral powder

Active substance

Tylvalosin (Tylvalosin tartrate) : 42,5 mg/g

ATC code

QJ01FA92 Tylvalosin

QJ01FA Macrolides

QJ01F Macrolides, lincosamides and streptogramins

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Pigs

Indications

The presence of the disease in the group must be established before the product is used.

• Treatment and metaphylaxis of swine enzootic pneumonia caused by Mycoplasma hyopneumoniae in pigs. At the recommended dose, lung lesions and weight loss are reduced but infection with Mycoplasma hyopneumoniae is not eliminated.

• Treatment of porcine proliferative enteropathy (ileitis) caused by Lawsonia intracellularis in groups where there is a diagnosis based on clinical history, postmortem findings and clinical pathology results.

• Treatment and metaphylaxis of swine dysentery, caused by Brachyspira hyodysenteriae in groups where the disease has been diagnosed.

Dose to be administered and administration route

For use in individual pigs on farms where only a small number of pigs are to receive the treatment. Larger groups should be treated with medicated feeding stuff containing the premix.

For treatment and metaphylaxis of swine enzootic pneumonia

The dose is 2.125 mg tylvalosin per kg bodyweight per day for 7 consecutive days. Secondary infection by organisms such as Pasteurella multocida and Actinobacillus pleuropneumoniae may complicate enzootic pneumonia and require specific medication.

For treatment of porcine proliferative enteropathy (ileitis)

The dose is 4.25 mg tylvalosin per kg bodyweight per day for 10 consecutive days.

For treatment and metaphylaxis of swine dysentery

The dose is 4.25 mg tylvalosin per kg bodyweight per day for 10 consecutive days.

This is achieved by thoroughly mixing the veterinary medicinal product into approximately 200– 500 g of feed and then thoroughly mixing this pre-mixture into the remainder of the daily ration. Scoops of 2 sizes are provided for measuring the correct amount of veterinary medicinal product for mixing with the daily ration, according to the schedule below. The feed containing the oral powder should be provided as the sole ration for the periods recommended above.

The pig to be treated should be weighed and the amount of feed that the pig is likely to consume should be estimated, based on a daily feed intake equivalent to 5% of bodyweight. Consideration must be given to pigs whose daily feed intake is reduced or restricted. The correct quantity of the veterinary medicinal product should be added to the estimated quantity of daily ration for each pig, in a bucket or similar receptacle, and thoroughly mixed.

The veterinary medicinal product should only be added to dry non-pelleted feed.

Swine enzootic pneumonia 2.125 mg/kg bodyweight
Bodyweight range (kg)	Scoop size	Number of scoops
7.5–12	1 ml	1
13–25	1 ml	2
26–38	1 ml	3
39–67	5 ml	1
68–134	5 ml	2
135–200	5 ml	3
201–268	5 ml	4

PPE (ileitis) and swine dysentery 4.25 mg/kg bodyweight
Bodyweight range (kg)	Scoop size	Number of scoops
7.5–12	1 ml	2
13–19	1 ml	3
20–33	5 ml	1
34–67	5 ml	2
68–100	5 ml	3
101–134	5 ml	4
135–200	5 ml	6
201–268	5 ml	8

NB: A level scoop of the product should be measured

Adverse reactions

None known.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the package leaflet for respective contact details.